ArticleJACC. Case reports2025
KCNQ1 and GJA1 Variants Associated With Arrhythmogenic Right Ventricular Cardiomyopathy With a Lethal Outcome.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArrhythmogenic right ventricular cardiomyopathy (ARVC) is mainly caused by desmosomal variants. Nondesmosomal ARVC is rare. CASE SUMMARY: A 31-year-old athlete experienced sudden cardiac death. Autopsy revealed ARVC and syndactyly. Genetic testing identified a heterozygous pathogenic KCNQ1 variant associated with long QT syndrome, and a heterozygous likely pathogenic GJA1 variant encoding connexin-43, a gap junction protein. No relative had ARVC or prolonged QTc interval; however, GJA1-positive relatives had either syndactyly or a gait disorder; both of these pathologies are associated with GJA1. DISCUSSION: Connexin-43 is essential for desmosomal function; however, ARVC causation has not been established. Cascade genetic and clinical testing suggests that the combination of both variants and lifelong endurance exercise may have precipitated the ARVC phenotype. TAKE-HOME MESSAGES: This is the first documented case linking GJA1 and KCNQ1 variants to ARVC. Comprehensive genetic and clinical family screening is vital for assessing the individual contribution of each variant to the diagnosis and arrhythmic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.